SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mercury Laboratories informs about 100 days campaign

04 Oct 2025 Evaluate
Mercury Laboratories has informed that the Investor Education and Protection Fund Authority, Ministry of Corporate Affairs has by circular dated July 16, 2025 requested companies to launch a 100 days Campaign – ‘Saksham Niveshak’, to reach out to shareholders whose dividend remain unpaid/unclaimed. In terms of above circular, it has enclosed communication for creating awareness among the shareholders to update their details and claim any unpaid or unclaimed dividends before they get transferred to the Investor Education and Protection Fund under 100 days Campaign viz. ‘Saksham Niveshak’.

The above information is a part of company’s filings submitted to BSE. 

Mercury Laboratories Share Price

799.00 0.00 (0.00%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×